about
Lack of association between measles virus vaccine and autism with enteropathy: a case-control studyNovel paramyxovirus associated with severe acute febrile disease, South Sudan and Uganda, 2012Nipah virus-associated encephalitis outbreak, Siliguri, IndiaGenetic characterization of measles viruses isolated in Turkey during 2000 and 2001.Review of the temporal and geographical distribution of measles virus genotypes in the prevaccine and postvaccine erasCharacterization of a novel coronavirus associated with severe acute respiratory syndromeSubacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognizedAssessing the Potential Cost-Effectiveness of Microneedle Patches in Childhood Measles Vaccination Programs: The Case for Further Research and Development.Progress toward measles elimination—Philippines, 1998-2014.Perspective on Global Measles Epidemiology and Control and the Role of Novel Vaccination StrategiesFunctional and structural characterization of neutralizing epitopes of measles virus hemagglutinin protein.Enzyme-linked immunospot assay detection of mumps-specific antibody-secreting B cells as an alternative method of laboratory diagnosisNipah virus: a recently emergent deadly paramyxovirus.Molecular characterization of Nipah virus, a newly emergent paramyxovirus.Molecular characterization of the polymerase gene and genomic termini of Nipah virus.Functional properties of the fusion and attachment glycoproteins of Nipah virus.Design of a small-molecule entry inhibitor with activity against primary measles virus strains.Recurrent zoonotic transmission of Nipah virus into humans, Bangladesh, 2001-2007Person-to-person transmission of Nipah virus in a Bangladeshi community.Genetic characterization of wild-type measles viruses isolated in China, 2006-2007.Use of monoclonal antibodies against Hendra and Nipah viruses in an antigen capture ELISAAntigenic and genetic characterization of the haemagglutinins of recent cocirculating strains of influenza B virus.Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States.Off Label Antiviral Therapeutics for Henipaviruses: New Light Through Old Windows.Evolutionary genetics of genotype H1 measles viruses in China from 1993 to 2012Measles outbreak in a highly vaccinated population, San Diego, 2008: role of the intentionally undervaccinated.Single endemic genotype of measles virus continuously circulating in China for at least 16 yearsReal-time reverse transcription-polymerase chain reaction assay for SARS-associated coronavirus.Evaluation of affymetrix severe acute respiratory syndrome resequencing GeneChips in characterization of the genomes of two strains of coronavirus infecting humans.Activity of polymerase proteins of vaccine and wild-type measles virus strains in a minigenome replication assay.Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins.Measles - United States, January 1-May 23, 2014.Distinct and overlapping roles of Nipah virus P gene products in modulating the human endothelial cell antiviral response.Successful respiratory immunization with dry powder live-attenuated measles virus vaccine in rhesus macaquesRecent resurgence of mumps in the United States.New measles virus genotype associated with outbreak, China.Triggering of the newcastle disease virus fusion protein by a chimeric attachment protein that binds to Nipah virus receptorsGenetic characterization of the hemagglutinin genes of wild-type measles virus circulating in china, 1993-2009Genotyping of measles virus in clinical specimens on the basis of oligonucleotide microarray hybridization patterns.Update on the global distribution of genotypes of wild type measles viruses.
P50
Q21144239-199170F1-B6E3-4072-A403-EDB98C9D8CE6Q24273381-2B68D6E0-82F1-4087-B18A-883B63A0155CQ24605727-C98E5B5F-F545-4700-89B7-28B5046EAEABQ24812552-11789B80-7AFB-476A-9FC3-75BAB993F615Q24814033-87D4E96F-9A37-43D7-96F9-85738167310DQ28202401-174C6F01-12FA-4446-A3F6-9B572DD35CFFQ28277883-DF747A60-B57B-4749-B9FA-FE704034B362Q30151736-91A6062B-C0C5-4E51-B5CD-434C690B9B1EQ30204214-FE00E2BB-42B4-4BDB-81D8-99E77ADF83B1Q30238913-81D8AC79-5C4E-406B-9089-DFD3138E37CAQ30423044-42A839E8-7431-4338-82AE-A0ED5B622BE8Q30431538-B34ECC42-CE4D-4887-95D3-84958C2441F9Q30596767-9BCA6417-A39A-4C2A-97C9-D4669E82A3EFQ30598149-688B3DB5-4595-49FB-92FD-5EFCC66D2611Q30658536-7BEFF3A1-70D6-44D9-9ABB-D47979EB0641Q30695260-B334EC2A-1A97-493C-9EAF-D697F42AB785Q33222430-8D4602F5-CEA5-4932-B1B5-903ECBA10DCFQ33628621-9CBE44CB-FDA9-4FC2-AB51-502CF47A12CEQ33884010-CD934514-8754-4A76-87E3-5A08F3C25C73Q33920088-7912942A-5878-4878-ACD8-EBC8E1244244Q33961230-5F151B6B-D2F8-4FD8-BE6C-E666ED0F0914Q33971139-A292E547-F69A-454D-A9DB-416BDD0E0F1DQ33998254-9AA4F6A4-B616-4BEC-98CC-C6E0228A7A66Q34021811-23842D90-12AF-452D-9AD5-46A280866E38Q34054288-050447C3-8CC4-43C5-ADD2-E941EA66009BQ34105917-853FA676-E0DD-4A29-801A-120A27CA96FDQ34244980-4A9CDD0E-4B9B-493C-879B-EE03018BF472Q34306956-52D8018D-09C1-40FA-BC33-BA78D6E2DCD4Q34316040-4C83E968-A80B-4EB7-AE6A-DC0BA44B799FQ34342086-582C652F-D558-4421-BF80-1F6984BA3F00Q34417623-42692F00-9E2B-475D-A069-E5C3F482F2BEQ34422941-76855A48-FFB4-4B7A-85B7-F811338A0408Q34456557-B3302A56-9D19-4372-8F55-CC505937352EQ34582862-DE4DB7B6-CFAC-4662-BF29-053158DE8C56Q34590390-66DBFEA8-88BA-46FC-9CF5-527419EC33ADQ34908003-923CD868-6CB3-42D1-8E9D-9A8C4D224863Q34978997-87276FB2-B4D5-45A9-AC89-09FE090BA4F1Q35000614-0C191E1D-5098-440B-93C7-9FE6C94D6AE4Q35073577-C0CD489A-A5CC-4392-8530-D4BE85792468Q35117520-7EAE5776-F073-4826-84CD-85E258739A59
P50
description
researcher
@en
wetenschapper
@nl
name
Paul A. Rota
@en
Paul A. Rota
@nl
type
label
Paul A. Rota
@en
Paul A. Rota
@nl
altLabel
P A Rota
@en
P Rota
@en
P. A. Rota
@en
P. Rota
@en
Paul A Rota
@en
Paul Rota
@en
Rota P
@en
Rota P. A.
@en
Rota P.
@en
Rota PA
@en
prefLabel
Paul A. Rota
@en
Paul A. Rota
@nl
P21
P31
P496
0000-0002-8595-4094